How Decentralized Clinical Trials Can Center Patient Care

The COVID-19 pandemic drove decentralized care models to new prominence, allowing patients to safely access care from home through telehealth. The pandemic has also pushed decentralized clinical trials (DCTs) to the forefront in clinical research. DCTs help expand access to experimental therapeutics by bringing the trial to the patient.

According to Medable, “After all, even during “normal” times, patients face numerous challenges in accessing traditional site-based clinical trials. Seventy percent of potential participants live more than two hours away from trial sites. This in turn creates additional burdens for patients, like:

• Finding transportation that accommodates their schedules and their mobility needs
• Finding and paying for child-care
• Rescheduling or getting time off from work”

To read more, click here.

(Source: Clinical Leader, June 6th, 2022)